Package 21130-061-05

Brand: naproxen sodium

Generic: naproxen sodium
NDC Package

Package Facts

Identity

Package NDC 21130-061-05
Digits Only 2113006105
Product NDC 21130-061
Product ID 21130-061_4650be91-1c5a-c650-e063-6394a90a4178
Description

50 TABLET in 1 BOTTLE (21130-061-05)

Marketing

Marketing Status
Marketed Since 2023-09-30
Brand naproxen sodium
Generic naproxen sodium
Sample Package No

Linked Drug Pages (1)

Naproxen Sodium ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4650be91-1c5a-c650-e063-6394a90a4178", "openfda": {"unii": ["9TN87S3A3C"], "rxcui": ["849574"], "spl_set_id": ["f2a297c2-3898-5e47-e053-2995a90ab3cc"], "manufacturer_name": ["Safeway, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "50 TABLET in 1 BOTTLE (21130-061-05)", "package_ndc": "21130-061-05", "marketing_start_date": "20230930"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (21130-061-09)", "package_ndc": "21130-061-09", "marketing_start_date": "20230930"}], "brand_name": "Naproxen Sodium", "product_id": "21130-061_4650be91-1c5a-c650-e063-6394a90a4178", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "21130-061", "generic_name": "Naproxen Sodium", "labeler_name": "Safeway, Inc", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Naproxen Sodium", "active_ingredients": [{"name": "NAPROXEN SODIUM", "strength": "220 mg/1"}], "application_number": "ANDA091353", "marketing_category": "ANDA", "marketing_start_date": "20230930", "listing_expiration_date": "20261231"}